Utility:
| In this study 36 active SLE patients were followed monthly. At each visit disease activity was scored using the SELENA-SLEDAI (excluding anti-dsDNA or complement components), and by physician's global assessment (PGA). Four anti-dsDNA tests were compared (QUANTA Lite, high avidity anti-dsDNA assays, QUANTA Flash, and CLIFT. Positivity was significantly higher for QUANTA Flash anti-dsDNA (83%) and CLIFT (96%). Anti-dsDNA antibodies determined by QUANTA Flash have value in monitoring SLE disease activity and QUANTA Flash was the only anti-dsDNA assay significantly associated with the change in physician's global assessment. |